Veterinary Medicines

CALCIUMVIT B12

Authorised
  • Cyanocobalamin
  • Calcium gluconate
  • Magnesium gluconate
Download as PDF

Product identification

Medicine name:
CALCIUMVIT B12
Active substance:
  • Cyanocobalamin
  • Calcium gluconate
  • Magnesium gluconate
Target species:
  • Cattle
  • Dog
  • Cat
  • Pig
  • Horse
Route of administration:
  • Intraperitoneal use
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Cyanocobalamin
    0.04
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium gluconate
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium gluconate
    60.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intraperitoneal use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Dog
    • Cat
    • Pig
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
  • Intramuscular use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Dog
    • Cat
    • Pig
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
  • Intravenous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Dog
    • Cat
    • Pig
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Dog
    • Cat
    • Pig
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11BA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."